<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:usg="https://explorer.usaid.gov">
  <iati-identifier>US-GOV-1-AID-688-P-00-07-00020</iati-identifier>
  <reporting-org ref="US-GOV-1" type="10">
   <narrative xml:lang="EN">U.S. Agency for International Development</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">HIV and STI Prevention and Control Project</narrative>
   <narrative xml:lang="FR">HIV et projet de pr&#xE9;vention et de contr&#xF4;le de STI</narrative>
  </title>
  <description>
   <narrative xml:lang="FR">Par le projet de pr&#xE9;vention et de contr&#xF4;le de HIV/STI, la CDC continuera &#xE0; fournir l&apos;assistance technique experte de renforcer la capacit&#xE9; de laboratoire (en particulier parmi des d&#xE9;positaires de GOM), de renforcer la capacit&#xE9; de GOMs de se rassembler, analyser, et emploie la date, et am&#xE9;liore le dialogue de politique, les structures, et les processus autour de la surveillance et de la pr&#xE9;vention de STI/HIV. La collaboration &#xE9;troite &#xE0; long terme de CDCs avec USAID continuera &#xE0; &#xEA;tre un mod&#xE8;le sous les principes de l&apos;harmonisation et de l&apos;int&#xE9;gration de d&#xE9;veloppement aux termes de GHI et de l&apos;accord de Paris. En outre, le travail de surveillance de CDCs sous la pr&#xE9;vention de HIV&amp;STI et le projet de contr&#xF4;le fournit les preuves les plus importantes sur lesquelles pour baser des interventions (un autre principe de GHI).</narrative>
   <narrative xml:lang="EN">Through the HIV/STI Prevention and Control project, CDC will continue to provide expert technical assistance to strengthen laboratory capacity (particularly among GOM stakeholders), strengthen the GOMs ability to collect, analyze, and use date, and improve policy dialogue, structures, and processes around STI/HIV surveillance and prevention. CDCs long-term close collaboration with USAID will continue to be a model under the principles of development harmonization and integration under GHI and the Paris Agreement. In addition, CDCs surveillance work under the HIV&amp;STI Prevention and Control Project provides the most important evidence on which to base interventions (another GHI principle).</narrative>
  </description>
  <participating-org ref="US-GOV-11" role="1" type="10">
   <narrative xml:lang="EN">Department of State</narrative>
  </participating-org>
  <participating-org ref="US-GOV-1" role="2" type="10">
   <narrative xml:lang="EN">U.S. Agency for International Development</narrative>
  </participating-org>
  <participating-org ref="US-GOV-1" role="3" type="10">
   <narrative xml:lang="EN">U.S. Agency for International Development</narrative>
  </participating-org>
  <participating-org ref="US-GOV-14" role="4" type="22">
   <narrative xml:lang="EN">U.S. Government - Department of Health and Human Services</narrative>
  </participating-org>
  <activity-status code="3"></activity-status>
  <activity-date iso-date="2007-10-25" type="1"></activity-date>
  <activity-date iso-date="2007-10-25" type="2"></activity-date>
  <activity-date iso-date="2016-09-30" type="3"></activity-date>
  <activity-date iso-date="2016-09-30" type="4"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">U.S. Agency for International Development</narrative>
   </organisation>
   <person-name>
    <narrative xml:lang="EN">Dana Alzouma</narrative>
   </person-name>
   <telephone>+1 202-712-0432</telephone>
   <email>aidtransparency@usaid.gov</email>
   <website>https://www.usaid.gov/mali</website>
   <mailing-address>
    <narrative xml:lang="EN">1300 Pennsylvania Ave NW, Washington DC 20004</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="4"></default-tied-status>
  <transaction ref="272287AFF6AB">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2012-12-31"></transaction-date>
   <value currency="USD" value-date="2012-12-31">164298.01</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="3001" vocabulary="99">
    <narrative xml:lang="EN">HIV/AIDS</narrative>
   </sector>
   <sector code="13040" vocabulary="1">
    <narrative xml:lang="EN">STD control including HIV/AIDS</narrative>
   </sector>
   <recipient-country code="ML"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2007" end="2008"></usg:fiscal-funding-year>
    <usg:main-account code="1095">Child Survival and Health Programs Fund, United States</usg:main-account>
    <usg:regular-account code="72"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="BD835221B4E5">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2013-03-31"></transaction-date>
   <value currency="USD" value-date="2013-03-31">16083.69</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="3001" vocabulary="99">
    <narrative xml:lang="EN">HIV/AIDS</narrative>
   </sector>
   <sector code="13040" vocabulary="1">
    <narrative xml:lang="EN">STD control including HIV/AIDS</narrative>
   </sector>
   <recipient-country code="ML"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2007" end="2008"></usg:fiscal-funding-year>
    <usg:main-account code="1095">Child Survival and Health Programs Fund, United States</usg:main-account>
    <usg:regular-account code="72"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="FB6DF1C3ADF8">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2013-06-30"></transaction-date>
   <value currency="USD" value-date="2013-06-30">25203.74</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="3001" vocabulary="99">
    <narrative xml:lang="EN">HIV/AIDS</narrative>
   </sector>
   <sector code="13040" vocabulary="1">
    <narrative xml:lang="EN">STD control including HIV/AIDS</narrative>
   </sector>
   <recipient-country code="ML"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2010" end="2011"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="A3923F65AC91">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2013-09-30"></transaction-date>
   <value currency="USD" value-date="2013-09-30">96826.59</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="3001" vocabulary="99">
    <narrative xml:lang="EN">HIV/AIDS</narrative>
   </sector>
   <sector code="13040" vocabulary="1">
    <narrative xml:lang="EN">STD control including HIV/AIDS</narrative>
   </sector>
   <recipient-country code="ML"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2010" end="2011"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="603B1CCB2B93">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2013-12-31"></transaction-date>
   <value currency="USD" value-date="2013-12-31">24095.37</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="3001" vocabulary="99">
    <narrative xml:lang="EN">HIV/AIDS</narrative>
   </sector>
   <sector code="13040" vocabulary="1">
    <narrative xml:lang="EN">STD control including HIV/AIDS</narrative>
   </sector>
   <recipient-country code="ML"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2010" end="2011"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="4905D13B1616">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-03-31"></transaction-date>
   <value currency="USD" value-date="2014-03-31">15065.46</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="3001" vocabulary="99">
    <narrative xml:lang="EN">HIV/AIDS</narrative>
   </sector>
   <sector code="13040" vocabulary="1">
    <narrative xml:lang="EN">STD control including HIV/AIDS</narrative>
   </sector>
   <recipient-country code="ML"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2007" end="2008"></usg:fiscal-funding-year>
    <usg:main-account code="1095">Child Survival and Health Programs Fund, United States</usg:main-account>
    <usg:regular-account code="72"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="684151C5ACAE">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-03-31"></transaction-date>
   <value currency="USD" value-date="2014-03-31">12477.46</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="3001" vocabulary="99">
    <narrative xml:lang="EN">HIV/AIDS</narrative>
   </sector>
   <sector code="13040" vocabulary="1">
    <narrative xml:lang="EN">STD control including HIV/AIDS</narrative>
   </sector>
   <recipient-country code="ML"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2010" end="2011"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="C85509C19378">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-09-30"></transaction-date>
   <value currency="USD" value-date="2014-09-30">-16432.65</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="3001" vocabulary="99">
    <narrative xml:lang="EN">HIV/AIDS</narrative>
   </sector>
   <sector code="13040" vocabulary="1">
    <narrative xml:lang="EN">STD control including HIV/AIDS</narrative>
   </sector>
   <recipient-country code="ML"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2010" end="2011"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="A911B3E55576">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2015-06-30"></transaction-date>
   <value currency="USD" value-date="2015-06-30">77062.46</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="3001" vocabulary="99">
    <narrative xml:lang="EN">HIV/AIDS</narrative>
   </sector>
   <sector code="13040" vocabulary="1">
    <narrative xml:lang="EN">STD control including HIV/AIDS</narrative>
   </sector>
   <recipient-country code="ML"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2010" end="2011"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="C91AE0044F02">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2015-09-30"></transaction-date>
   <value currency="USD" value-date="2015-09-30">44034.87</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="3001" vocabulary="99">
    <narrative xml:lang="EN">HIV/AIDS</narrative>
   </sector>
   <sector code="13040" vocabulary="1">
    <narrative xml:lang="EN">STD control including HIV/AIDS</narrative>
   </sector>
   <recipient-country code="ML"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2010" end="2011"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="1886A330DA1D">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2016-09-30"></transaction-date>
   <value currency="USD" value-date="2016-09-30">-236732.16</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="3001" vocabulary="99">
    <narrative xml:lang="EN">HIV/AIDS</narrative>
   </sector>
   <sector code="13040" vocabulary="1">
    <narrative xml:lang="EN">STD control including HIV/AIDS</narrative>
   </sector>
   <recipient-country code="ML"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2010" end="2011"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <conditions attached="0"></conditions>
  <usg:mechanism-signing-date iso-date="2007-10-25"></usg:mechanism-signing-date>
  <usg:state-location>
   <narrative>Mali</narrative>
  </usg:state-location>
  <usg:tec1>
   <narrative>263267.00</narrative>
  </usg:tec1>
 </iati-activity>
</iati-activities>
